CEO comments on successful financing round to accelerate portfolio expansion

We are excited to announce that SenzaGen has secured financing to accelerate portfolio expansion within non-animal testing.With this, we are poised for an even brighter growth path.

The funding enables us to better meet customer needs within in vitro testing, fostering innovation and advancing non-animal testing solutions.

CEO Peter Nählstedt comments: “This achievement underscores our commitment to non-animal testing, innovation, and excellence. We are proud of the progress we have made and look forward to continuing to drive the transition from animal testing to methods better suited to reflect human biology. This will contribute to creating safer and more efficacious products for society.”

CEO interview by Redeye analyst Gustaf Meyer (ENG)